PTC Therapeutics, Inc.
PTCT
$75.25
-$0.92-1.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.71B | 2.00B | 2.04B | 1.15B | 1.02B |
| Total Receivables | 203.07M | 196.13M | 210.50M | 158.55M | 199.98M |
| Inventory | 52.69M | 34.06M | 21.68M | 23.19M | 35.67M |
| Prepaid Expenses | 44.73M | 42.85M | 46.42M | 22.93M | 22.52M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 7.40M | -- |
| Total Current Assets | 2.01B | 2.27B | 2.32B | 1.37B | 1.28B |
|
|
|||||
| Total Current Assets | 2.01B | 2.27B | 2.32B | 1.37B | 1.28B |
| Net Property, Plant & Equipment | 137.65M | 113.35M | 116.78M | 117.66M | 122.64M |
| Long-term Investments | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
| Goodwill | 82.34M | 82.34M | 82.34M | 82.34M | 82.34M |
| Total Other Intangibles | 396.47M | 143.81M | 118.45M | 118.79M | 330.37M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.44M | 21.78M | 21.42M | 20.70M | 25.34M |
| Total Assets | 2.64B | 2.63B | 2.66B | 1.71B | 1.84B |
|
|
|||||
| Total Accounts Payable | 36.62M | 26.51M | 15.15M | 17.27M | 13.29M |
| Total Accrued Expenses | 246.23M | 244.21M | 219.14M | 261.62M | 301.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 561.41M | 279.10M | 264.75M | 271.18M | 274.37M |
| Total Finance Division Other Current Liabilities | 21.99M | 77.99M | 96.35M | 30.90M | 21.40M |
| Total Other Current Liabilities | 21.99M | 77.99M | 96.35M | 30.90M | 21.40M |
| Total Current Liabilities | 866.25M | 627.81M | 595.39M | 580.98M | 610.71M |
|
|
|||||
| Total Current Liabilities | 866.25M | 627.81M | 595.39M | 580.98M | 610.71M |
| Long-Term Debt | 1.82B | 2.12B | 2.14B | 2.11B | 2.11B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 109.32M | 85.07M | 87.39M | 90.52M | 98.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.58M | 7.82M | 22.43M | 22.23M | 77.99M |
| Total Liabilities | 2.80B | 2.84B | 2.84B | 2.80B | 2.90B |
|
|
|||||
| Common Stock & APIC | 2.67B | 2.63B | 2.61B | 2.57B | 2.53B |
| Retained Earnings | -2.83B | -2.85B | -2.78B | -3.65B | -3.58B |
| Treasury Stock & Other | 5.93M | 7.36M | -13.95M | -25.89M | -4.34M |
| Total Common Equity | -155.76M | -206.55M | -185.76M | -1.10B | -1.05B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -155.76M | -206.55M | -185.76M | -1.10B | -1.05B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -155.76M | -206.55M | -185.76M | -1.10B | -1.05B |
|
|
|||||